PROTEINS AND PROTEIN CONJUGATES WITH HIGH HYDROPHOBICITY Russian patent published in 2020 - IPC A61K9/50 A61K47/64 A61K47/69 

Abstract RU 2712644 C2

FIELD: medicine; pharmaceuticals.

SUBSTANCE: group of inventions relates to pharmacy, in particular to microspheres for controlled release of protein and methods for production thereof. Microsphere contains a biodegradable polymer selected from a group consisting of polylactide; polyglycolide; poly(d,1-lactide-co-glycolide); polycaprolactone; polyorthoester; copolymer of polyether and polyether; and polylactide and polyethylene glycol copolymer; and a protein mixture selected from a group consisting of: protein-polyethylene glycol conjugate and hydrophobic anion of organic acid; protein and hydrophobic anion of organic acid; combinations thereof, wherein the organic acid includes pamoic acid, dioctyl sulphosuccinic acid, furoic acid or mixtures thereof; and where the microsphere is formed by a method comprising: adding an organic acid to a protein-polyethylene glycol or protein conjugate in a water-immiscible solvent in an organic phase to form a water-immiscible solution, wherein addition takes place without presence of water. Also disclosed is a method of producing a salt of a protein-polyethylene glycol conjugate with high hydrophobicity and a method of producing a microsphere which provides controlled release of an active agent which contains a salt of a protein-polyethylene glycol conjugate. This method involves preparing an aqueous protein solution. Aqueous protein solution contains protein and a buffer solution providing a certain pH. Method also involves reacting polyethylene glycol with protein to form a protein-polyethylene glycol conjugate. Method also includes protonation of amino group in protein-polyethylene glycol conjugate due to hydrophobic organic acid in organic phase. As a result of said protonation, a salt of a protein-polyethylene glycol conjugate is formed, which contains a hydrophobic anion, which increases hydrophobicity of the salt of the protein-polyethylene glycol conjugate.

EFFECT: group of inventions provides preparing drug preparations with a constant profile of protein release.

40 cl, 11 dwg, 2 tbl, 14 ex

Similar patents RU2712644C2

Title Year Author Number
METHODS FOR AMINO GROUP PEGYLATION TO OBTAIN SITE-SPECIFIC CONJUGATES OF PROTEINS 2016
  • Rosendahl, Mary S.
  • Mantripragada, Sankaram B.
RU2730848C2
DELIVERED PHARMACEUTICAL COMPOSITIONS WITH CONTROLLED RELEASE OF BIOLOGICALLY ACTIVE COMPOUNDS 2005
  • Jukhua Li
  • Chien Bendzhamin
RU2390355C2
POLYMER PROTEIN MICROPARTICLES 2012
  • Chen Hunter
  • Walsh Scott
RU2768492C2
POLYMERIC PROTEIN MICROPARTICLES 2012
  • Chen Khanter
  • Uolsh Skott
RU2642664C2
HIGH STABILITY PHARMACEUTICAL COMPOSITIONS 2007
  • Li Jukhua
  • Chien Bendzhamin
RU2427383C2
PHARMACEUTICAL COMPOSITIONS WITH A SELECTED DURATION OF RELEASE 2017
  • Li, Yukhua
  • Guarino, Endryu
RU2756514C1
METHOD FOR PRODUCING PHYSIOLOGICALLY ACTIVE POLYPEPTIDE COMPLEX 2012
  • Kim Dae Jin
  • Jang Myung Hyun
  • Kim Seung Su
  • Lee Jong Soo
  • Choi Jae Hyuk
  • Kwon Se Chang
RU2624129C2
SUSTAINED-RELEASE DELIVERY COMPOSITION AND A METHOD FOR STABILIZING PROTEINS IN THE MANUFACTURING PROCESS 2014
  • Tran Sajmon Kh.
  • Vu Sindi
RU2720412C2
MICROPARTICLE AND PHARMACEUTICAL COMPOSITION THEREOF 2009
  • Kakizava Josinori
  • Nisio Rejdzi
  • Mitizoe Dzundzi
  • Kojva Masakazu
  • Ida Nobuo
  • Khirano Tajsuke
  • Kosi Joitiro
RU2490009C2
PROLONGED-RELEASE PHARMACEUTICAL COMPOSITIONS FOR PEPTIDE DELIVERY 2007
  • Li Jukhua
  • Chien Bendzhamin
RU2456018C2

RU 2 712 644 C2

Authors

Rozendal Meri S.

Mantripragada Sankaram B.

Gomes Eliana B.

Dates

2020-01-30Published

2015-12-01Filed